Carbohydrate-dependent B cell activation by fucose-binding bacterial lectins

Isabel Wilhelm,Ella Levit-Zerdoun,Johanna Jakob,Sarah Villringer,Marco Frensch,Rudolf Übelhart,Alessia Landi,Peter Müller,Anne Imberty,Roland Thuenauer,Julie Claudinon,Hassan Jumaa,Michael Reth,Hermann Eibel,Elias Hobeika,Winfried Römer
DOI: https://doi.org/10.1126/scisignal.aao7194
2019-03-05
Abstract:Bacterial lectins are typically multivalent and bind noncovalently to specific carbohydrates on host tissues to facilitate bacterial adhesion. Here, we analyzed the effects of two fucose-binding lectins, BambL from Burkholderia ambifaria and LecB from Pseudomonas aeruginosa, on specific signaling pathways in B cells. We found that these bacterial lectins induced B cell activation, which, in vitro, was dependent on the cell surface expression of the B cell antigen receptor (BCR) and its co-receptor CD19, as well as on spleen tyrosine kinase (Syk) activity. The resulting release of intracellular Ca2+ was followed by an increase in the cell surface abundance of the activation marker CD86, augmented cytokine secretion, and subsequent cell death, replicating all of the events that are observed in vitro upon canonical and antigen-mediated B cell activation. Moreover, injection of BambL in mice resulted in a substantial, BCR-independent loss of B cells in the bone marrow with simultaneous, transient enlargement of the spleen (splenomegaly), as well as an increase in the numbers of splenic B cells and myeloid cells. Together, these data suggest that bacterial lectins can initiate polyclonal activation of B cells through their sole capacity to bind to fucose.
What problem does this paper attempt to address?